AAAAAA

   
Results: 1-11 |
Results: 11
What are the options for oral agent treatment of type 2 diabetes?
Authors: Berger, M Muhlhauser, I
Citation: M. Berger et I. Muhlhauser, What are the options for oral agent treatment of type 2 diabetes?, DIFFICULT DIABETES, 2001, pp. 88-93
Prognosis of persons with type 1 diabetes on intensified insulin therapy in relation to nephropathy
Authors: Muhlhauser, I Sawicki, PT Blank, M Overmann, H Bender, R Berger, M
Citation: I. Muhlhauser et al., Prognosis of persons with type 1 diabetes on intensified insulin therapy in relation to nephropathy, J INTERN M, 248(4), 2000, pp. 333-341
Non-linear effects of blood pressure and glycosylated haemoglobin on progression of diabetic nephropathy
Authors: Sawicki, PT Bender, R Berger, M Muhlhauser, I
Citation: Pt. Sawicki et al., Non-linear effects of blood pressure and glycosylated haemoglobin on progression of diabetic nephropathy, J INTERN M, 247(1), 2000, pp. 131-138
Evidence-based patient information in diabetes
Authors: Muhlhauser, I Berger, M
Citation: I. Muhlhauser et M. Berger, Evidence-based patient information in diabetes, DIABET MED, 17(12), 2000, pp. 823-829
Predictors of mortality and end-stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy
Authors: Muhlhauser, I Overmann, H Bender, R Jorgens, V Berger, M
Citation: I. Muhlhauser et al., Predictors of mortality and end-stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy, DIABET MED, 17(10), 2000, pp. 727-734
Evidence-based therapy of type 2 diabetes
Authors: Berger, M Muhlhauser, I
Citation: M. Berger et I. Muhlhauser, Evidence-based therapy of type 2 diabetes, DIABETES IN THE NEW MILLENNIUM, 2000, pp. 171-176
Effects of intensified antihypertensive treatment in diabetic nephropathy:mortality and morbidity results of a prospective controlled 10-year study
Authors: Trocha, AK Schmidtke, C Didjurgeit, U Muhlhauser, I Bender, R Berger, M Sawicki, PT
Citation: Ak. Trocha et al., Effects of intensified antihypertensive treatment in diabetic nephropathy:mortality and morbidity results of a prospective controlled 10-year study, J HYPERTENS, 17(10), 1999, pp. 1497-1503
Rationale for the use of insulin therapy alone as the pharmacological treatment of type 2 diabetes
Authors: Berger, M Jorgens, V Muhlhauser, I
Citation: M. Berger et al., Rationale for the use of insulin therapy alone as the pharmacological treatment of type 2 diabetes, DIABET CARE, 22, 1999, pp. C71-C75
Intensified treatment and education of type 1 diabetes as clinical routine
Authors: Muller, UA Femerling, M Reinauer, KM Risse, A Voss, M Jorgens, V Berger, M Muhlhauser, I
Citation: Ua. Muller et al., Intensified treatment and education of type 1 diabetes as clinical routine, DIABET CARE, 22, 1999, pp. B29-B34
Diabetes care and patient-oriented outcomes
Authors: Berger, M Muhlhauser, I
Citation: M. Berger et I. Muhlhauser, Diabetes care and patient-oriented outcomes, J AM MED A, 281(18), 1999, pp. 1676-1678
Amputations and mortality in elderly insulin-treated patients with type 2 diabetes
Authors: Spraul, M Schonbach, AM Muhlhauser, I Berger, M
Citation: M. Spraul et al., Amputations and mortality in elderly insulin-treated patients with type 2 diabetes, ZBL CHIR, 124(6), 1999, pp. 501-507
Risultati: 1-11 |